Prism Medico and Pharmacy Limited engages in the wholesale and retail of straw, fodder, and other animal/poultry feed in India.
Flawless balance sheet and overvalued.
Share Price & News
How has Prism Medico and Pharmacy's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 512217's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: 512217 underperformed the Indian Food industry which returned -3.8% over the past year.
Return vs Market: 512217 underperformed the Indian Market which returned -30.6% over the past year.
Price Volatility Vs. Market
How volatile is Prism Medico and Pharmacy's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Prism Medico and Pharmacy undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 512217's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 512217's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 512217 is unprofitable, so we can't compare its PE Ratio to the Food industry average.
PE vs Market: 512217 is unprofitable, so we can't compare its PE Ratio to the Indian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 512217's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 512217 is good value based on its PB Ratio (0.6x) compared to the IN Food industry average (0.7x).
How is Prism Medico and Pharmacy forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Prism Medico and Pharmacy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Prism Medico and Pharmacy's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- Prism Medico and Pharmacy competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Food, Beverage & Tobacco industry.
How has Prism Medico and Pharmacy performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 512217 is currently unprofitable.
Growing Profit Margin: 512217 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 512217 is unprofitable, and losses have increased over the past 5 years at a rate of -7% per year.
Accelerating Growth: Unable to compare 512217's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 512217 is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (20.6%).
Return on Equity
High ROE: 512217 has a negative Return on Equity (-3.25%), as it is currently unprofitable.
How is Prism Medico and Pharmacy's financial position?
Financial Position Analysis
Short Term Liabilities: 512217's short term assets (₹145.9M) exceed its short term liabilities (₹116.9M).
Long Term Liabilities: 512217's short term assets (₹145.9M) exceed its long term liabilities (₹311.0K).
Debt to Equity History and Analysis
Debt Level: 512217 is debt free.
Reducing Debt: 512217 has no debt compared to 5 years ago when its debt to equity ratio was 0.01%.
Inventory Level: 512217 has a high level of physical assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if 512217's debt is covered by short term assets.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 512217 has been profitable on average in the past, therefore cash runway is not a concern.
Forecast Cash Runway: Insufficient data to determine if 512217 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Prism Medico and Pharmacy's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 512217's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 512217's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 512217's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 512217's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 512217's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Prism Medico and Pharmacy has no CEO, or we have no data on them.
|Executive Director||2.25yrs||₹30.00k||no data|
|Executive Director||0.42yr||no data||no data|
|Independent Director||4.83yrs||₹3.00k||no data|
|Independent Director||2yrs||₹3.00k||no data|
|Non Executive Director||0.42yr||no data||no data|
Experienced Board: 512217's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Prism Medico and Pharmacy Limited's company bio, employee growth, exchange listings and data sources
- Name: Prism Medico and Pharmacy Limited
- Ticker: 512217
- Exchange: BSE
- Founded: 2002
- Industry: Agricultural Products
- Sector: Food, Beverage & Tobacco
- Market Cap: ₹72.155m
- Shares outstanding: 6.06m
- Website: https://www.prismmedico.com
Number of Employees
- Prism Medico and Pharmacy Limited
- D-118, Industrial Area
- Phase VII
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|512217||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Apr 2005|
Prism Medico and Pharmacy Limited engages in the wholesale and retail of straw, fodder, and other animal/poultry feed in India. The company was formerly known as Woolite Mercantile Company Limited and changed its name to Prism Medico and Pharmacy Limited in January 2012. Prism Medico and Pharmacy Limited was incorporated in 2002 and is based in Mohali, India.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/31 12:37|
|End of Day Share Price||2020/03/31 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.